Drug Pipeline

SHR-1316 Injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07168200 A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy… Advanced Cervical Cancer Recruiting
Phase 2
NCT07268040 A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With… Malignant Solid Tumors Recruiting
Phase 1/2
NCT06474455 A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor… Advanced Solid Tumors Recruiting
Sponsors Running SHR-1316 Injection Trials
Shanghai Hengrui Pharmaceutical Co., Ltd. (2) Shanghai Shengdi Pharmaceutical Co., Ltd (1)
Disease Areas
Cervical Cancer (1)
Get alerts when SHR-1316 Injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free